Thursday, August 20, 2026
HomeTagsIambic Therapeutics

Tag: Iambic Therapeutics

Healthcare

Iambic Therapeutics Appoints Michael Secora as CFO & CDO

Iambic Therapeutics, a clinical-stage biotechnology company developing novel medicines using its AI-driven discovery and development platform, announced that Michael Secora, Ph.D. will be its...
Healthcare

Iambic Therapeutics Selects Lambda Cloud to Help Meet Compute Demands of its Generative AI Drug Discovery Models

Lambda, the GPU cloud company founded by AI engineers and powered by NVIDIA GPUs, announced that Iambic Therapeutics, a clinical-stage biotechnology company developing novel...
Healthcare

Iambic Therapeutics Announces First Patient Dosed in Phase 1 Clinical Study of IAM1363, a Highly Selective HER2 Inhibitor for the Treatment of Solid Tumors

Iambic Therapeutics, a biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, announced that the first patient has been dosed in its...
Healthcare

Iambic Therapeutics Announces New Research Published in Nature Machine Intelligence Demonstrating the Capabilities of Its Generative AI NeuralPLexer Technology to Predict Protein-Ligand Complex Structures

Advances in AI Platform Provide an Ability to Rapidly Predict, Identify and Design Biomolecular Structures to Accelerate the Pace and Reduce the Cost of...

Recent Published

About Us

Discover the future of artificial intelligence at AITech365. Explore the latest AI news, delve into insightful interviews with industry experts, and stay informed about the most exciting and trending topics shaping the world of AI.

Latest

Popular

Quick Link

© 2026 AITech365. All Rights Reserved. Website Undertaking: Data Demand